bench_entry
TL3 Regular · Portland, ME, US
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 24 November 2024 · last posted 5d
143 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #58 · Practice › Interactions · 23 Jul 2026 · 5 likes I read post #56 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Here for the analytics and not much else Replied, post #59 · Lounge › Introductions · 19 Jul 2026 · 22 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #96 · Analytics › Method validation · 19 Jul 2026 · 22 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #84 · Sourcing › Independent verification · 12 Jul 2026 · 4 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #9 · Start Here › How to Ask · 9 Jul 2026 · 0 likes post #8 answers the question as asked. The question underneath it is different. Disagreeing with an answer you got: cite what you disagree with, say what contradicts…
-
Transit times by route, from a logged dataset Started this topic · Sourcing › Logistics · 9 Jul 2026 · 6 likes Transit times by route, from a logged dataset Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers…
-
What a reversed-phase purity number actually is Replied, post #30 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 2 likes This follows post #27 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Bioimpedance and hydration: why the number moves Replied, post #71 · Outcomes › Body composition · 5 Jul 2026 · 0 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
What changed in 2026, by region — does this still hold? Replied, post #19 · Access › International · 30 Jun 2026 · 0 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Alcohol: what is documented and what is folklore Replied, post #80 · Practice › Interactions · 27 Jun 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Follow-up: Search filters: what is missing Replied, post #140 · Meta › Site feedback · 27 Jun 2026 · 6 likes Coming back to post #138, because the follow-up matters more than the original answer. Feature requests: if the site would work better with a feature it does not have…
-
What a regulator's shortage notice actually authorises Started this topic · Sourcing › Regulatory · 22 Jun 2026 · 20 likes What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. A logistics question,…
-
Batch numbers that do not match the vial label Replied, post #32 · Sourcing › Red flags · 21 Jun 2026 · 0 likes On post #28 — agreed on the reasoning, with one qualification. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #52 · Outcomes › Progress reports · 19 Jun 2026 · 10 likes Coming back to post #50, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Request: a per-category review queue Replied, post #44 · Meta › Feature requests · 18 Jun 2026 · 0 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Run-in periods and the population they select Replied, post #138 · Evidence › Trials · 17 Jun 2026 · 2 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #104 · Access › Insurance & coverage · 15 Jun 2026 · 26 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Racemisation and why it is invisible to a mass measurement Replied, post #74 · Analytics › Impurities & related substances · 12 Jun 2026 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #50 · Analytics › Home & field testing · 11 Jun 2026 · 3 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #73 · Access › Insurance & coverage · 9 Jun 2026 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #54 · Access › Pricing · 8 Jun 2026 · 26 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Follow-up: External review after an internal denial Replied, post #4 · Access › Insurance & coverage · 7 Jun 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A calculator that gives a right answer to the wrong question Replied, post #26 · Data & Tools › Calculators · 7 Jun 2026 · 10 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Spreadsheets: an appreciation — what changed since Replied, post #64 · Lounge › Off topic · 7 Jun 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Getting a referral rather than a refusal Replied, post #13 · Clinical › Prescriber conversations · 5 Jun 2026 · 2 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #12 · Practice › Storage & stability · 1 Jun 2026 · 5 likes This follows post #9 rather than contradicting it. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #66 · Evidence › Preprints · 30 May 2026 · 7 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Official shortage notices and what they authorise Replied, post #66 · Access › Shortages · 24 May 2026 · 1 like Coming back to post #64, because the follow-up matters more than the original answer. Allocation and rationing: during severe shortages, suppliers might ration…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #23 · Analytics › Impurities & related substances · 20 May 2026 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #108 · Practice › Interactions · 19 May 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
What a certificate commits its issuer to — one year on Replied, post #70 · Analytics › COA interpretation · 18 May 2026 · 8 likes I read post #68 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Prescription portability between countries Replied, post #35 · Access › International · 17 May 2026 · 17 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #98 · Research Methods › Statistics · 7 May 2026 · 0 likes This follows post #95 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #11 · Analytics › Mass spectrometry · 7 May 2026 · 0 likes This follows post #8 rather than contradicting it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect…
-
The headache that turns out to be dehydration — the long version Replied, post #30 · Nutrition & Training › Hydration & electrolytes · 3 May 2026 · 16 likes On post #26 — agreed on the reasoning, with one qualification. Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #67 · Devices › Syringes & needles · 28 Apr 2026 · 0 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
GLP-1 receptor distribution: central and peripheral Replied, post #37 · Pharmacology › Receptor biology · 24 Apr 2026 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
An 18-month record including the parts that went badly Replied, post #3 · Outcomes › Progress reports · 23 Apr 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Longitudinal report with the method stated: same scale, same time of day, same conditions. A…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #63 · Data & Tools › Calculators · 19 Apr 2026 · 7 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #25 · Practice › Dosing & titration · 16 Apr 2026 · 0 likes This follows post #22 rather than contradicting it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
-
Why chargeback is not the safety net people assume Replied, post #8 · Sourcing › Payments · 9 Apr 2026 · 3 likes Worth separating two things that post #4 runs together. No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #13 · Sourcing › Logistics · 4 Apr 2026 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #47 · Clinical › Comorbidities · 29 Mar 2026 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: is percentage weight change the right endpoint? Replied, post #5 · Evidence › Journal club · 20 Mar 2026 · 12 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Follow-up: Search filters: what is missing Replied, post #57 · Meta › Site feedback · 20 Mar 2026 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #64 · Analytics › Mass spectrometry · 10 Mar 2026 · 3 likes Coming back to post #62, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] What a purity-only report leaves out Replied, post #45 · Sourcing › Independent verification · 6 Mar 2026 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #105 · Evidence › Study critique · 3 Mar 2026 · 8 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #5 · Evidence › Journal club · 21 Feb 2026 · 1 like On the opening post — agreed on the reasoning, with one qualification. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #5 · Clinical › Bloodwork · 17 Feb 2026 · 16 likes Picking up post #2: that is the part I would want checked first. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #2 · Sourcing › Logistics · 16 Feb 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #22 · Practice › Storage & stability · 10 Feb 2026 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #113 · Sourcing › Independent verification · 8 Feb 2026 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #41 · Practice › Reconstitution · 7 Feb 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #6 · Outcomes › Progress reports · 5 Feb 2026 · 8 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Liver enzymes drifting down and what that usually means Replied, post #52 · Clinical › Bloodwork · 1 Feb 2026 · 1 like I read post #50 twice before replying, because I had assumed the opposite. Reference intervals: constructed to contain the central 95% of a reference population, which…
-
Run-in periods and the population they select Replied, post #53 · Evidence › Trials · 20 Jan 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #13 · Regional › UK & Ireland · 18 Jan 2026 · 1 like Coming back to post #11, because the follow-up matters more than the original answer. Supply and shortage resilience: both UK and Ireland sourced primarily from…
-
A partial dose because the pen emptied mid-injection Replied, post #86 · Practice › Administration · 10 Jan 2026 · 11 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Filter needles: when they help and what they cost you Replied, post #21 · Devices › Syringes & needles · 8 Jan 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 20 Dec 2025 · 6 likes On the opening post — agreed on the reasoning, with one qualification. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing.…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #48 · Sourcing › Independent verification · 19 Dec 2025 · 11 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
The decimal-point error, and the habit that catches it Replied, post #68 · Practice › Reconstitution · 16 Dec 2025 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #21 · Practice › Interactions · 16 Dec 2025 · 1 like This follows post #18 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
The decimal-point error, and the habit that catches it Replied, post #37 · Practice › Reconstitution · 15 Dec 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #11 · Practice › Interactions · 12 Dec 2025 · 20 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Dead volume across syringe and needle combinations Replied, post #37 · Devices › Syringes & needles · 12 Dec 2025 · 6 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #39 · Compounds › Other compounds · 24 Nov 2025 · 9 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #9 · Practice › Reconstitution · 22 Nov 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #17 · Practice › Dosing & titration · 20 Nov 2025 · 1 like Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
[2026 update] What steady state means for the decision to escalate Replied, post #130 · Practice › Dosing & titration · 18 Nov 2025 · 1 like How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
EMA product information as a primary source Replied, post #68 · Regional › European Union · 14 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #23 · Compounds › Tirzepatide · 14 Nov 2025 · 21 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #40 · Compounds › Tirzepatide · 11 Nov 2025 · 7 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #89 · Documentation › Doc review · 8 Nov 2025 · 22 likes This follows post #86 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Temperature loggers worth the money — the long version Replied, post #63 · Devices › Cold chain · 26 Oct 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A 40-week log with the measurement method stated Replied, post #52 · Outcomes › Progress reports · 22 Oct 2025 · 6 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Payment mechanics and the recovery options that do not exist Replied, post #35 · Sourcing › Payments · 20 Oct 2025 · 2 likes Picking up post #32: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Payment mechanics and the recovery options that do not exist Replied, post #10 · Sourcing › Payments · 18 Oct 2025 · 20 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
Sleep tracking data and its considerable limitations Replied, post #26 · Wellbeing › Sleep · 18 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A preprint whose numbers changed substantially at publication Replied, post #83 · Evidence › Preprints · 8 Oct 2025 · 32 likes I read post #81 twice before replying, because I had assumed the opposite. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers…
-
Temperature loggers worth the money — the long version Replied, post #52 · Devices › Cold chain · 6 Oct 2025 · 20 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Compounds this community declines to help with, and why Replied, post #63 · Compounds › Other compounds · 5 Oct 2025 · 31 likes Worth separating two things that post #59 runs together. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
-
Second pass at: The mass-error checker and its intended scope Replied, post #24 · Data & Tools › Calculators · 25 Sep 2025 · 25 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #38 · Lounge › Off topic · 15 Sep 2025 · 27 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #45 · Analytics › HPLC & UHPLC · 8 Sep 2025 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #2 · Compounds › Retatrutide · 7 Sep 2025 · 7 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #38 · Evidence › Preprints · 23 Aug 2025 · 0 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #76 · Evidence › Trials · 18 Aug 2025 · 17 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #26 · Compounds › Tirzepatide · 13 Aug 2025 · 4 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Request: a diff view for wiki revisions — the long version Replied, post #23 · Meta › Feature requests · 26 Jul 2025 · 17 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
A field-by-field walk through a certificate of analysis Replied, post #45 · Analytics › COA interpretation · 15 Jul 2025 · 7 likes post #44 is right about the mechanism and I think understates the practical bit. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Pooling trials with different estimands — what changed since Started this topic · Evidence › Meta-analyses · 30 Jun 2025 · 7 likes Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #25 · Sourcing › Regulatory · 22 Jun 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #118 · Clinical › Comorbidities · 18 Jun 2025 · 17 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Which panel is worth repeating and which is worth ignoring Replied, post #40 · Clinical › Bloodwork · 17 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #26 · Compounds › Semaglutide · 13 Jun 2025 · 16 likes post #25 answers the question as asked. The question underneath it is different. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
-
Half-life, steady state, and accumulation worked through Replied, post #101 · Pharmacology › Pharmacokinetics · 11 Jun 2025 · 0 likes post #100 is right about the mechanism and I think understates the practical bit. Albumin binding: semaglutide binds albumin through a fatty side chain, which…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 5 Jun 2025 · 2 likes On post #17 — agreed on the reasoning, with one qualification. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #49 · Evidence › Journal club · 1 Jun 2025 · 12 likes This follows post #46 rather than contradicting it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question?…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #33 · Meta › Wiki maintenance · 1 Jun 2025 · 26 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Progressive overload when the scale is falling Replied, post #3 · Nutrition & Training › Resistance training · 30 May 2025 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Why quantitation is the hard part, not detection Replied, post #10 · Analytics › Home & field testing · 27 Apr 2025 · 6 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #100 · Evidence › Journal club · 20 Apr 2025 · 6 likes Worth separating two things that post #96 runs together. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped…
-
Temperature logging at home: what is worth the effort Started this topic · Practice › Storage & stability · 19 Apr 2025 · 0 likes Temperature logging at home: what is worth the effort — setting out what I have, and where I think it stops being reliable. Practical question with the units stated,…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #79 · Documentation › Doc review · 28 Mar 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Adjudicated events and why the definition matters — the long version Replied, post #68 · Evidence › Trials · 27 Mar 2025 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 25 Mar 2025 · 3 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Reading order for a first week here, and what to skip until later Replied, post #40 · Start Here › Welcome · 17 Mar 2025 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #110 · Compounds › Other compounds · 9 Mar 2025 · 12 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #38 · Devices › Syringes & needles · 6 Mar 2025 · 5 likes Picking up post #35: that is the part I would want checked first. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #25 · Evidence › Journal club · 5 Mar 2025 · 22 likes This follows post #22 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Charge states for a 4 kDa peptide, worked through Replied, post #3 · Analytics › Mass spectrometry · 1 Mar 2025 · 19 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Adjudicated events and why the definition matters — the long version Replied, post #24 · Evidence › Trials · 25 Feb 2025 · 0 likes Picking up post #21: that is the part I would want checked first. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
-
Triple agonism: additive, synergistic, or neither? Replied, post #20 · Compounds › Retatrutide · 20 Feb 2025 · 13 likes I read post #18 twice before replying, because I had assumed the opposite. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #87 · Sourcing › Regulatory · 17 Feb 2025 · 0 likes Picking up post #84: that is the part I would want checked first. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #92 · Compounds › Other compounds · 17 Feb 2025 · 19 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #40 · Access › International · 12 Feb 2025 · 24 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Distinguishing a deletion sequence by mass alone Replied, post #38 · Analytics › Mass spectrometry · 1 Feb 2025 · 1 like Worth separating two things that post #34 runs together. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report…
-
Canadian access and provincial variation Replied, post #28 · Regional › North America · 28 Jan 2025 · 31 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #56 · Data & Tools › Calculators · 18 Jan 2025 · 5 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #11 · Compounds › Oral incretins · 25 Dec 2024 · 10 likes This follows post #8 rather than contradicting it. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual…
-
Isotonicity and what happens when you get it wrong Replied, post #7 · Pharmacology › Formulation chemistry · 24 Dec 2024 · 15 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Fixed versus detachable needles: the trade-offs Replied, post #65 · Devices › Syringes & needles · 22 Dec 2024 · 9 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #10 · Devices › Syringes & needles · 17 Dec 2024 · 18 likes Worth separating two things that post #6 runs together. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #62 · Compounds › Semaglutide · 13 Dec 2024 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #29 · Practice › Reconstitution · 29 Nov 2024 · 5 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #59 · Compounds › Tirzepatide · 28 Nov 2024 · 8 likes post #58 answers the question as asked. The question underneath it is different. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how…
-
What a seizure notice actually says Replied, post #10 · Sourcing › Logistics · 21 Nov 2024 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Taste changes and food aversion, reported and discussed Replied, post #41 · Practice › Side effects · 15 Nov 2024 · 1 like post #40 answers the question as asked. The question underneath it is different. Nausea: the most common side effect and the most dose- and titration-dependent one. It…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #118 · Compounds › Other compounds · 15 Nov 2024 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #148 · Clinical › Bloodwork · 27 Oct 2024 · 0 likes On post #144 — agreed on the reasoning, with one qualification. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #86 · Practice › Dosing & titration · 19 Oct 2024 · 1 like Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Progressive overload when the scale is falling — one year on Replied, post #92 · Nutrition & Training › Resistance training · 26 Sep 2024 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reporting a discrepancy without making an allegation Replied, post #86 · Sourcing › Vendor reports · 22 Sep 2024 · 3 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Food noise reducing and the disorientation that can follow Replied, post #7 · Wellbeing › Mental health · 14 Sep 2024 · 0 likes This follows post #4 rather than contradicting it. Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #10 · Compounds › Tirzepatide · 4 Sep 2024 · 18 likes Picking up post #7: that is the part I would want checked first. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #74 · Nutrition & Training › Hydration & electrolytes · 3 Sep 2024 · 20 likes Worth separating two things that post #70 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #27 · Devices › Syringes & needles · 28 Aug 2024 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #3 · marked as the solution · Analytics › Mass spectrometry · 9 Aug 2024 · 11 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #98 · Compounds › Retatrutide · 23 Jul 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #64 · Practice › Interactions · 18 Jul 2024 · 1 like SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Assessing a warm arrival: the decision process — one year on Replied, post #47 · Sourcing › Logistics · 30 May 2024 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…